Such medications are just one part of a necessary, holistic approach that includes diet, exercise, and addressing significant ...

Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their ...

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better ...

Eli Lilly has launched weight-loss drug Mounjaro in India, priced at Rs 3,500 per injection for a 2.5mg dose. Will high costs ...

(Reuters) - (This April 1 story has been corrected to say that the company also offers the branded version of Wegovy, not just cheaper versions of the treatment, in paragraph 3. It was previously ...

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

Extending coverage for the medications through Medicare could cost $35 billion over nine years, a congressional analysis ...

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...

The growing number of Australians with obesity is causing economic damage but should the taxpayer fund weight-loss drugs?

Eli Lilly sues two compounders over tirzepatide after FDA lifts Zepbound, Mounjaro shortage status in key GLP-1 legal test.

The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a proposal put forth by the Biden ...